Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fighting type 2 diabetes: Formulation strategies for peptide-based therapeutics
Carlos Bendicho-Lavilla, Iria Seoane‐Viaño, Francisco J. Otero‐Espinar, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 621-636
Open Access | Times Cited: 18

Showing 18 citing articles:

Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetes
Xingyue Wang, You Wang, Junjie Hou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
To infinity and beyond: Strategies for fabricating medicines in outer space
Iria Seoane‐Viaño, Jun Jie Ong, Abdul W. Basit, et al.
International Journal of Pharmaceutics X (2022) Vol. 4, pp. 100121-100121
Open Access | Times Cited: 23
Preparation of semaglutide long-acting injectable microcapsules with physicochemical properties, long-term stability, and pharmacokinetics and pharmacodynamics
Ravi Maharjan, Duck Soo Lim, Hye Jung Baik, et al.
Journal of Pharmaceutical Investigation (2024) Vol. 54, Iss. 5, pp. 667-681
Closed Access | Times Cited: 4
Porous silicon and silica carriers for delivery of peptide therapeutics
Jiachen Yan, Prakriti Siwakoti, Siuli Shaw, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 12, pp. 3549-3567
Open Access | Times Cited: 4
Systematic review of peptide nanoparticles for improved diabetes outcomes: insights and opportunities
Reuben Samson Dangana, Michael Ben Okon, Ikuomola Emmanuel Orire, et al.
Discover Nano (2025) Vol. 20, Iss. 1
Open Access
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis
Qian Zhao, Jiale Dong, Han Liu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1283-1301
Open Access | Times Cited: 8
On demand regulation of blood glucose level by biocompatible oxidized starch-Con A nanogels for glucose-responsive release of exenatide
Jie Bai, Huijuan Zhang, Zhi Yang, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 673-684
Closed Access | Times Cited: 12
Enhanced oral and pulmonary delivery of biomacromolecules via amplified transporter targeting
Xin Xiao, Lie Zhang, Mingjie Ni, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 152-167
Closed Access | Times Cited: 2
Development of inert coatings to prevent drug retention in 3D-printed diffusion cells
Carlos Bendicho-Lavilla, Victoria Díaz-Tomé, Iria Seoane‐Viaño, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124256-124256
Open Access | Times Cited: 2
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges
Tanisha Tabassum Sayka Khan, Zara Sheikh, Simin Maleknia, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 7, pp. 1081-1101
Closed Access | Times Cited: 2
Intravitreal implants manufactured by supercritical foaming for treating retinal diseases
Carlos Bendicho-Lavilla, Iria Seoane‐Viaño, Víctor Santos‐Rosales, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 342-355
Open Access | Times Cited: 5
Phenolipid JE improves metabolic profile and inhibits gluconeogenesis via modulating AKT-mediated insulin signaling in STZ-induced diabetic mice
Guihua Wang, Jialin Xu, Hang Ma, et al.
Pharmacological Research (2022) Vol. 187, pp. 106569-106569
Open Access | Times Cited: 8
Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
Yaochen Xie, Qian Zhou, Qiaojun He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 6, pp. 2383-2402
Open Access | Times Cited: 7
Oral nano-formulation improves pancreatic islets dysfunction via lymphatic transport for antidiabetic treatment
Lin Hou, Xueyuan Peng, Ruiting Wang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 7, pp. 3137-3152
Open Access | Times Cited: 6
Exploring the complexities of drug formulation selection, storage, and shelf‐life for exploration spaceflight
Vernie Daniels, E. S. Williams
British Journal of Clinical Pharmacology (2023)
Closed Access | Times Cited: 1
Porous silicon and silica carriers for delivery of peptide therapeutics
Jiachen Yan, Prakriti Siwakoti, Ganesh R. Kokil, et al.
Research Square (Research Square) (2024)
Open Access
Clinical Benefits of 3D Printing in Healthcare
Atheer Awad, Iria Seoane‐Viaño, Abdul W. Basit, et al.
(2024), pp. 187-210
Closed Access
Optimizing expression, purification, structural and functional assessments of a novel dimeric incretin (GLP-1cpGLP-1)
Rawayh Muslim Albaghlany, Mohammad Bagher Shahsavani, Masaru Hoshino, et al.
Biochimie (2023) Vol. 223, pp. 133-146
Closed Access
Page 1

Scroll to top